Cargando…
Elevated TIMP-1 expression is associated with a prometastatic phenotype, disease relapse, and poor survival in neuroblastoma
Approximately two-thirds of patients with neuroblastoma are found to have metastatic disease at time of diagnosis with frequent skeletal, lymph node, central nervous system, and liver involvement. Using a serial in vivo splenic injection model, we have isolated an aggressive subclone (BE(2)-C/LM2) f...
Autores principales: | Paul, Pritha, Rellinger, Eric J., Qiao, Jingbo, Lee, Sora, Volny, Natasha, Padmanabhan, Chandrasekhar, Romain, Carmelle V., Mobley, Bret, Correa, Hernan, Chung, Dai H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669914/ https://www.ncbi.nlm.nih.gov/pubmed/29137288 http://dx.doi.org/10.18632/oncotarget.19664 |
Ejemplares similares
-
Targeting Gastrin-Releasing Peptide Suppresses Neuroblastoma Progression via Upregulation of PTEN Signaling
por: Paul, Pritha, et al.
Publicado: (2013) -
Gli1 Transcriptional Activity is Negatively Regulated by AKT2 in Neuroblastoma
por: Paul, Pritha, et al.
Publicado: (2013) -
Identification of α-N-catenin as a novel tumor suppressor in neuroblastoma
por: Qiao, Jingbo, et al.
Publicado: (2019) -
Isoxazole compound ML327 blocks MYC expression and tumor formation in neuroblastoma
por: Rellinger, Eric J., et al.
Publicado: (2017) -
The Prometastatic Microenvironment of the Liver
por: Vidal-Vanaclocha, Fernando
Publicado: (2008)